These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35812381)

  • 1. Screening Novel Vaccine Candidates for
    Zhang J; Li J; Hu K; Zhou Q; Chen X; He J; Yin S; Chi Y; Liao X; Xiao Y; Qin H; Zheng Z; Chen J
    Front Immunol; 2022; 13():902066. PubMed ID: 35812381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
    Kashyap M; Jaiswal V; Farooq U
    Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes.
    Khan MAA; Ami JQ; Faisal K; Chowdhury R; Ghosh P; Hossain F; Abd El Wahed A; Mondal D
    Parasit Vectors; 2020 Apr; 13(1):196. PubMed ID: 32295617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome based screening of epitope ensemble vaccine candidates against dreadful visceral leishmaniasis using immunoinformatics approach.
    Singh G; Pritam M; Banerjee M; Singh AK; Singh SP
    Microb Pathog; 2019 Nov; 136():103704. PubMed ID: 31479726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis.
    Lakshmi BS; Wang R; Madhubala R
    Vaccine; 2014 Jun; 32(30):3816-22. PubMed ID: 24814525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis.
    Dikhit MR; ; Kumar A; Amit A; Dehury B; Nathsharma YP; Ansari MY; Ali V; Topno RK; Das V; Pandey K; Sahoo GC; Bimal S; Das P
    J Cell Biochem; 2018 Jan; 119(1):378-391. PubMed ID: 28585770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells.
    Coler RN; Goto Y; Bogatzki L; Raman V; Reed SG
    Infect Immun; 2007 Sep; 75(9):4648-54. PubMed ID: 17606603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.
    Baharia RK; Tandon R; Sharma T; Suthar MK; Das S; Siddiqi MI; Saxena JK; Sundar S; Dube A
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003557. PubMed ID: 25745863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An In-depth Proteomic Map of Leishmania donovani Isolate from Post Kala-azar Dermal Leishmaniasis (PKDL) Patient.
    Routaray CB; Kumar A; Sundar S; Sathe G; Pawar H; Pai K
    Acta Parasitol; 2022 Jun; 67(2):687-696. PubMed ID: 35020128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of dominant epitope-based vaccines encoding Gp63, Kmp-11 and Amastin against visceral leishmaniasis.
    Zhang J; He J; Liao X; Xiao Y; Liang C; Zhou Q; Chen H; Zheng Z; Qin H; Chen D; Chen Q; Li J; Chen J
    Immunobiology; 2021 May; 226(3):152085. PubMed ID: 33910113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular, biochemical characterization and assessment of immunogenic potential of cofactor-independent phosphoglycerate mutase against Leishmania donovani: a step towards exploring novel vaccine candidate.
    Tandon R; Chandra S; Baharia RK; Misra P; Das S; Rawat K; Siddiqi MI; Sundar S; Dube A
    Parasitology; 2018 Apr; 145(4):508-526. PubMed ID: 28691653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analyses of immunogenic T-cell epitopes of LeIF and PpSP15 proteins from Leishmania major and sand fly saliva used as model antigens for the design of a multi-epitope vaccine to control leishmaniasis.
    Bordbar A; Bagheri KP; Ebrahimi S; Parvizi P
    Infect Genet Evol; 2020 Jun; 80():104189. PubMed ID: 31931259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of four proteins of Leishmania donovani to guide epitopes vaccine design and drug targets selection.
    He J; Huang F; Li J; Chen Q; Chen D; Chen J
    Acta Trop; 2019 Mar; 191():50-59. PubMed ID: 30582920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.
    Selvapandiyan A; Dey R; Gannavaram S; Solanki S; Salotra P; Nakhasi HL
    Vaccine; 2014 Jun; 32(31):3895-901. PubMed ID: 24837513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoinformatics based design and prediction of proteome-wide killer cell epitopes of
    Kashif M; Hira SK; Manna PP
    J Biomol Struct Dyn; 2022; 40(21):10578-10591. PubMed ID: 34219625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative phosphoproteomic analysis unravels MAPK1 regulated phosphoproteins in Leishmania donovani.
    Kaur P; Anand A; Bhat A; Maras JS; Goyal N
    J Proteomics; 2021 May; 240():104189. PubMed ID: 33757882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Label-Free Quantitative Proteomic Analysis of Three Strains of Viscerotropic Leishmania Isolated from Patients with Different Epidemiological Types of Visceral Leishmaniasis in China.
    Wei FR; Gao CH; Wang JY; Yang YT; Shi F; Zheng B
    Acta Parasitol; 2021 Dec; 66(4):1366-1386. PubMed ID: 34019278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A
    J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.